Materials Today Bio,
Journal Year:
2024,
Volume and Issue:
28, P. 101198 - 101198
Published: Aug. 9, 2024
Bioprinting
is
a
groundbreaking
technology
that
enables
precise
distribution
of
cell-containing
bioinks
to
construct
organoid
models
accurately
reflect
the
characteristics
tumors
Journal of Hematology & Oncology,
Journal Year:
2023,
Volume and Issue:
16(1)
Published: July 14, 2023
Early
detection
and
diagnosis
of
many
cancers
is
very
challenging.
Late
stage
a
cancer
always
leads
to
high
mortality
rates.
It
imperative
develop
novel
more
sensitive
effective
therapeutic
methods
for
treatments.
The
development
new
treatments
has
become
crucial
aspect
medical
advancements.
Nanobots,
as
one
the
most
promising
applications
nanomedicines,
are
at
forefront
multidisciplinary
research.
With
progress
nanotechnology,
nanobots
enable
assembly
deployment
functional
molecular/nanosized
machines
increasingly
being
utilized
in
treatment.
In
recent
years,
various
practical
have
transitioned
from
theory
practice,
vitro
experiments
vivo
applications.
this
paper,
we
review
analyze
advancements
treatments,
with
particular
emphasis
on
their
key
fundamental
features
drug
delivery,
tumor
sensing
diagnosis,
targeted
therapy,
minimally
invasive
surgery,
other
comprehensive
At
same
time,
discuss
challenges
potential
research
opportunities
revolutionizing
future,
expected
sophisticated
capable
performing
multiple
functions
tasks,
ultimately
becoming
true
nanosubmarines
bloodstream.
Big Data and Cognitive Computing,
Journal Year:
2023,
Volume and Issue:
7(3), P. 147 - 147
Published: Aug. 30, 2023
The
future
of
innovative
robotic
technologies
and
artificial
intelligence
(AI)
in
pharmacy
medicine
is
promising,
with
the
potential
to
revolutionize
various
aspects
health
care.
These
advances
aim
increase
efficiency,
improve
patient
outcomes,
reduce
costs
while
addressing
pressing
challenges
such
as
personalized
need
for
more
effective
therapies.
This
review
examines
major
robotics
AI
pharmaceutical
medical
fields,
analyzing
advantages,
obstacles,
implications
In
addition,
prominent
organizations
research
institutions
leading
way
these
technological
advancements
are
highlighted,
showcasing
their
pioneering
efforts
creating
utilizing
state-of-the-art
solutions
medicine.
By
thoroughly
current
state
care
exploring
possibilities
further
progress,
this
work
aims
provide
readers
a
comprehensive
understanding
transformative
power
evolution
healthcare
sector.
Striking
balance
between
embracing
technology
preserving
human
touch,
investing
R&D,
establishing
regulatory
frameworks
within
ethical
guidelines
will
shape
systems.
seamless
integration
systems
benefit
patients
providers.
Bioactive Materials,
Journal Year:
2023,
Volume and Issue:
28, P. 386 - 401
Published: June 16, 2023
Organoids
are
in
vitro
model
systems
that
mimic
the
complexity
of
organs
with
multicellular
structures
and
functions,
which
provide
great
potential
for
biomedical
tissue
engineering.
However,
their
current
formation
heavily
relies
on
using
complex
animal-derived
extracellular
matrices
(ECM),
such
as
Matrigel.
These
often
poorly
defined
chemical
components
exhibit
limited
tunability
reproducibility.
Recently,
biochemical
biophysical
properties
hydrogels
can
be
precisely
tuned,
offering
broader
opportunities
to
support
development
maturation
organoids.
In
this
review,
fundamental
ECM
vivo
critical
strategies
design
organoid
culture
summarized.
Two
typically
derived
from
natural
synthetic
polymers
applicability
improve
organoids
presented.
The
representative
applications
incorporating
into
highlighted.
Finally,
some
challenges
future
perspectives
also
discussed
developing
advanced
technologies
toward
supporting
research.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: May 27, 2023
Light-based
3D
bioprinting
is
now
employed
widely
to
fabricate
geometrically
complex
constructs
for
various
biomedical
applications.
However,
the
inherent
light
scattering
defect
creates
significant
challenges
in
patterning
dilute
hydrogels
form
high-fidelity
structures
with
fine-scale
features.
Herein,
we
introduce
a
photoinhibiting
approach
that
can
effectively
suppress
effect
via
mechanism
of
simultaneous
photoabsorption
and
free-radical
reaction.
This
biocompatible
significantly
improves
printing
resolution
(~1.2
-
~2.1
pixels
depending
on
swelling)
shape
fidelity
(geometric
error
less
than
5%),
while
minimising
costly
trial-and-error
procedures.
The
capability
using
different
demonstrated
by
manufacturing
scaffolds
featuring
intricate
multi-sized
channels
thin-walled
networks.
Importantly,
cellularised
gyroid
(HepG2)
are
fabricated
successfully,
exhibiting
high
cell
proliferation
functionality.
strategy
established
this
study
promotes
printability
operability
light-based
systems,
allowing
numerous
new
applications
tissue
engineering.
Biofabrication,
Journal Year:
2023,
Volume and Issue:
15(2), P. 025005 - 025005
Published: Jan. 10, 2023
Realizing
the
translational
impacts
of
three-dimensional
(3D)
bioprinting
for
cancer
research
necessitates
innovation
in
workflows
which
integrate
affordability,
user-friendliness,
and
biological
relevance.
Herein,
we
demonstrate
'BioArm',
a
simple,
yet
highly
effective
extrusion
platform,
can
be
folded
into
carry-on
pack,
rapidly
deployed
between
bio-facilities.
BioArm
enabled
reconstruction
compartmental
tumoroids
with
cancer-associated
fibroblasts
(CAFs),
forming
shell
each
tumoroid.
The
3D
printed
core-shell
showedde
novosynthesized
extracellular
matrices,
enhanced
cellular
proliferation
compared
to
tumour
alone
spheroid
culture.
Further,
thein
vivophenotypes
CAFs
normally
lost
after
conventional
2D
co-culture
re-emerged
bioprinted
model.
Embedding
an
immune
cell-laden
collagen
matrix
permitted
tracking
interaction
cells
tumoroids,
subsequent
simulated
immunotherapy
treatments.
Our
deployable
workflow
could
significantly
widen
accessibility
replicating
multi-compartmental
architectures
microenvironment,
developing
strategies
drug
testing
future.
Trends in biotechnology,
Journal Year:
2023,
Volume and Issue:
42(5), P. 648 - 663
Published: Dec. 9, 2023
Bioprinting
shows
excellent
potential
for
preclinical
tumor
modeling,
with
significant
advantages
over
2D
cell
cultures
in
replicating
the
microenvironment
(TME).
Recently,
use
of
organoids
bioprinting
models
has
emerged
as
a
groundbreaking
approach
to
simulate
volumetric
tissues.
This
synergetic
fabrication
method
leverages
spatial
and
geometric
control
assemble
heterogeneous
TME
components,
while
maintain
collective
behaviors.
In
this
review,
we
provide
landscape
latest
progress
on
convergence
3D
organoids.
Furthermore,
discuss
incorporate
organ-on-a-chip
improve
biomimicry
predictability
therapeutic
performance.
Lastly,
address
challenges
personalized
medicine
predictive
clinical
integration.
International Journal of Bioprinting,
Journal Year:
2023,
Volume and Issue:
9(5), P. 748 - 748
Published: May 9, 2023
Leveraging
three-dimensional
(3D)
bioprinting
in
the
fields
of
tissue
engineering
and
regenerative
medicine
has
rapidly
accelerated
progress
toward
development
living
constructs
biomedical
devices.
Ongoing
vigorous
research
pursued
3D
vitro
models
to
replicate
key
aspects
human
physiology
by
incorporating
relevant
cell
populations
adequate
environmental
cues.
Given
their
advantages
being
able
intimately
mimic
heterogeneity
complexity
native
counterparts,
hold
promise
as
alternatives
conventional
cultures
or
animal
for
translational
application
model
physiology/pathology
drug
screening.
Research
highlighted
importance
models,
a
sophisticated
biomanufacturing
strategy
is
vitally
required.
In
particular,
vascularization
critical
prolonged
survival
functional
maturation
engineered
tissues,
which
remained
one
major
challenges
establishment
physiologically
models.
To
this
end,
can
efficiently
generate
solid
reproducible
vascularized
with
high
architectural
compositional
similarity
leading
improve
structural
tissue-specific
functionality.
Multiple
strategies
have
been
developed
vascularize
tissues
spatially
controlled
patterning
vascular
precursors
generating
readily
perfusable
structures.
This
review
presents
an
overview
advanced
development.
We
present
elements
rebuilding
vasculature
3D-bioprinted
discuss
recent
achievements
using
bioprinting.
Finally,
we
delineate
current
future
outlooks
bioprinting-based
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 19, 2024
Synthetic
extracellular
matrix
(ECM)
mimics
that
can
recapitulate
the
complex
biochemical
and
mechanical
nature
of
native
tissues
are
needed
for
advanced
models
development
disease.
Biomedical
research
has
heavily
relied
on
use
animal-derived
biomaterials,
which
is
now
impeding
their
translational
potential
convoluting
biological
insights
gleaned
from
in
vitro
tissue
models.
Natural
hydrogels
have
long
served
as
a
convenient
effective
cell
culture
tool,
but
advances
materials
chemistry
fabrication
techniques
present
promising
new
avenues
creating
xenogenic-free
ECM
substitutes
appropriate
organotypic
microphysiological
systems.
However,
significant
challenges
remain
synthetic
matrices
approximate
structural
sophistication,
complexity,
dynamic
functionality
tissues.
This
review
summarizes
key
properties
ECM,
discusses
recent
approaches
used
to
systematically
decouple
tune
these
matrices.
The
importance
mechanics,
such
viscoelasticity
plasticity,
also
discussed,
particularly
within
context
organoid
engineered
Emerging
design
strategies
mimic
reviewed,
multi-network
hydrogels,
supramolecular
chemistry,
assembled
monomers.